Metrics as of 10/15/2026, 05:16 AM (Berlin time), refresh in progress.
aTyr Pharma Stock
aTyr Pharma, Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Sanjay S. Shukla
- Employees
- 58
- Market cap
- $18 M
- IPO
- 07/05/2015
aTyr Pharma, Inc., a biopharmaceutical firm established in San Diego, California, in 2005, is dedicated to the discovery and advancement of therapeutic solutions. Operating within the United States, the company's research focuses on pioneering novel immunological pathways to address various medical conditions. Its…
aTyr Pharma stock: price history
1D
-8.9%
1W
-34.1%
1M
-52.8%
6M
-78.2%
YTD
-76.6%
1Y
-82.4%
2Y
-91.8%
5Y
–
10Y
–
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~12% stronger price swings than usual
Ask the agents about aTyr Pharma
Analyst assessment of aTyr Pharma
PRICE TARGET LOW
US$1.00
CONSENSUS
US$5.13
MEDIAN
US$1.25
PRICE TARGET HIGH
US$17.00
0
STRONG BUY
3
BUY
7
HOLD
0
SELL
0
STRONG SELL
10
TOTAL · Hold
As of: 20/05/2026
aTyr Pharma stock metrics
P/E
-0.3
P/B
0.37
EV/EBITDA
-0.22
RETURN ON EQUITY
-21.1%
NET MARGIN
0.0%
DEBT/EQUITY
0.23
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
97.4%
FLOAT SHARES
95,515,301
AVG. DAILY VOLUME (30D)
6,067,097
Insider transactions (SEC)
SCHIMMEL PAUL
Dividends & Stock splits
Comparable stocks
Frequently asked questions about aTyr Pharma stock
What does aTyr Pharma do?
aTyr Pharma, Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Sanjay S. Shukla, the company employs around 58 people.
The IPO was on 07/05/2015; the stock trades on NASDAQ under the ticker ATYR.
What do analysts say about aTyr Pharma stock?
10 analysts rate the stock, the consensus is Hold (as of 20/05/2026).
The average price target is US$5.13, ranging from US$1.00 to US$17.00, with a median of US$1.25.
This is an external assessment, not a statement by Market Jury.
When does aTyr Pharma report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 12% stronger than usual.
Does aTyr Pharma pay a dividend?
No, aTyr Pharma currently does not pay a dividend.
Which stocks are comparable to aTyr Pharma?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get aTyr Pharma stock analyzed?
Clicking "Analyze stock" lets five strategies assess aTyr Pharma against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.